A small zinc-binding group (ZBG) library of deoxy-2-C-branched-monosaccharides, for example, 1,5-anhydroglucitols, consisting of either monodentate ligand binding carboxylic acids or bidentate ligand binding hydroxamic acids, were prepared to assess the zinc affinity of the putative metalloenzyme 2-acetamido-2-deoxy-a-D-glucopyranosyl-(1?6)-phosphatidylinositol de-N-acetylase (EC 3.5.1.89) of glycosylphosphatidylinositol biosynthesis. The N-ureido thioglucoside was also synthesised and added to the ZBG library because a previous N-ureido analogue, synthesised by us, had inhibitory activity against the aforementioned de-N-acetylase, presumably via the N-ureido motif.
Introduction
Glycosylphosphatidylinositol (GPI) acts as a membrane anchor for a small but significant proportion of higher eukaryote cellsurface glycoproteins that are particularly abundant in protozoan parasites such as Trypanosoma brucei, the causative agent of African sleeping sickness in humans and the related disease Nagana in cattle. 1 The structure, biosynthesis, and function of GPI anchors and related molecules have been extensively reviewed. [1] [2] [3] [4] Disruption of GPI biosynthesis in the clinically relevant bloodstream form of T. brucei has been genetically [5] [6] [7] [8] and chemically 9 validated as a drug target.
A key early step in the biosynthesis of the GPI anchors is the de-N-acetylation of 2-acetamido-2-deoxy-a-D-glucopyranosyl-(1?6)-phosphatidylinositol 10 [a-D-GlcpNAc-PI (1, Fig. 1 )] to form a-D-GlcpNH 2 -PI (2, Fig. 1 ). De-N-acetylation is a prerequisite for subsequent processing of 2 that leads to mature GPI anchor precursors. 11 In T. brucei, de-N-acetylation is followed by mannosylation and subsequent inositol-acylation of 2, whereas in mammalian cells the order of these reactions is reversed. 12, 13 Previously, we have shown 14 that mammalian and trypanosomal a-D-GlcpNAc-PI de-N-acetylases are zinc metalloenzymes, proposed a mechanism of action similar to that of zinc peptidases and postulated that known zinc binding motifs 15, 16 such as the N-hydroxyurea analogue 3 ( Fig. 1 ), 17 could act as inhibitors. Here, we have designed and synthesised a small library of deoxymonosaccharides [5-12 ( Fig. 2) ] containing recognisable zinc binding groups (ZBGs), that is, carboxylic acids and hydroxamic acids, as well as a potentially new ZBG, the ureido derivative, that should continue to probe the trypanosomal a-D-GlcpNAc-PI de-Nacetylase. A good starting point for our compound library was the earlier work by Hindsgaul and co-workers 18, 19 which demonstrated the effectiveness of 1,5-anhydro-2-deoxy-D-glucitol hydroxamic acids, for example 7, 19 as ZBG probes. The hydroxamic acid 7 was resynthesised and included in the compound library because 7 was shown to be a potent inhibitor of LpxC, 19 presumably via zinc chelation, and could serve as the standard by which to compare the potency of the other analogues in the library. Therefore, compounds 5, 6 and 8 resemble those of Hindsgaul et al. whereby the 2-C appendage is either a hydroxamic acid or a carboxylic acid ZBG moiety. Compounds 9-11 were synthesised to supply potential glycosyl donors for another project but might also exhibit some degree of inhibition towards the trypanosome de-N-acetylase enzyme. Lastly, the N-ureido thioglycoside 12 was fashioned because of previous inhibitory data of the N-ureido-GlcNAc-PI derivative 4
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( Fig. 1) 
A solution of the benzylidene compound 14 19 (20 mg, 0.05 mmol) in AcOH (2 mL) containing 10% palladium on carbon (10 mg) was stirred under a slight overpressure of hydrogen at room temperature for 4 h. The reaction mixture was filtered through a pad of Celite and concentrated under reduced pressure. The residue was purified by FCC (10:1:0.02 CHCl 3 -MeOH-AcOH) to furnish a brown paste 5 (9 mg, 59%), which was indistinguishable from that obtained by the following procedure.
Method B.
A solution of the benzylidene compound 14 19 (40 mg, 0.10 mmol) in THF (2 mL) and 96% (aq) TFA (0.5 mL)
was stirred at room temperature for 3 h. The reaction mixture was concentrated under reduced pressure and co-evaporated with toluene (2 Â 5 mL). The residue was purified with the same solvent system as in method A to give the acid 5 (21 mg, 70%): R f 0. 
A solution of the benzylidene derivative 15 (58 mg, 0.20 mmol) in AcOH (10 mL) containing 10% palladium on carbon (29 mg) was stirred under a slight overpressure of hydrogen at room temperature for 3 h. The reaction mixture was filtered through a pad of Celite and concentrated under reduced pressure. The resulting residue was purified by an RPC C18 column (10% MeOH) to furnish the carboxylic acid 6 (32 mg, 80%): R f 0.40 (10% MeOH); ½a 
1,3,4,6-Tetra-O-acetyl-2-C-carboxymethyl-2-deoxy-a-Dglucopyranose (21)
A solution of sodium chlorite (2.58 g, 28.56 mmol) and sodium dihydrogen phosphate (3.92 g, 32.63 mmol) in water (20 mL) was added dropwise to a solution of the aldehyde 20 (724 mg, 1.931 mmol) in tert-BuOH (56.7 mL, 604 mmol) and amylene (17 mL, 203 mmol). The reaction mixture was stirred for 1 h then diluted with ice water and extracted with EtOAc (2 Â 50 mL). The combined organic extracts were washed with brine (30 mL), dried (Na 2 SO 4 ), and concentrated under reduced pressure. The residue was purified by FCC (1:1:0.02 light petroleum-EtOAc-AcOH) to furnish the acid 21 (709 mg, 94%): R f 0. 27 
2-C-Carboxymethyl-2-deoxy-D-glucopyranose (9)
To a solution of benzoylated compound 21 (93 mg, 0.238 mmol) in MeOH (2 mL) was added 0.03 M sodium methoxide in MeOH (6.2 mL, 0.186 mmol) at room temperature. After 48 h, the reaction mixture was neutralised with Amberlite IR-120 (H + ) ion-exchange resin, filtered and the filtrate was concentrated under reduced pressure; followed by co-evaporation with water (5 Â 5 mL). The residue was purified by FCC (3:1:0.02 CH 2 Cl 2 -MeOH-AcOH) to
give the carboxylic acid 9 as an a:b (1.5:1) mixture (27 mg, 51%): 3.2.14. Phenyl 2-C-carboxymethyl-2-deoxy-1-thio-a-Dglucopyranoside (10) To a stirred mixture of the triacetate 26 (75 mg, 0.170 mmol) in acetone (10 mL) at 56°C was added dropwise a solution of concentrated hydrochloric acid (1 mL) in water (1.8 mL). Stirring was continued overnight at 56°C, whereafter the mixture was neutralised with TEA, concentrated under reduced pressure and co-evaporated with toluene (2 Â 5 mL). The residue was purified by an RPC C18 column (55% MeOH) to furnish the carboxylic acid as white needles 10 (40 mg, 75%): mp 144-146°C; R f 0.38 (55% MeOH); ½a Potassium cyanate (278 mg, 3.42 mmol) was added to a suspension of the known 25 amino-glucopyranoside 28 (607 mg, 2.24 mmol) in water (15 mL). The mixture was stirred in total darkness at room temperature for 4 days. Whereafter, the water was evaporated to dryness under reduced pressure and the residue was co-evaporated with toluene (3 Â 20 mL). RPC (25% CH 3 
